Purchases and Sales Made in Q2 2022 in Mainz Biomed N.V. (MYNZ)
This table provides information about the institutional ownership of Mainz Biomed N.V. (MYNZ) during Q2 2022. The information is specifically focused on institutions that hold shares of MAINZ BIOMED N.V..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 10, 2022
Q2 2022
|
Citigroup Inc
|
BUY
|
- |
752New |
$6.7K - $11.7K
|
752
$188
|
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
SELL
|
- |
-81- 5.61% |
$722 - $1.26K
|
1.36K
$341
|
|
|
Aug 15, 2022
Q2 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-262Closed |
$2.33K - $4.06K
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-477Closed |
$4.25K - $7.39K
|
0
$0
|
|
|
Jul 28, 2022
Q2 2022
|
National Bank Of Canada
|
SELL
|
- |
-500Closed |
$4.46K - $7.75K
|
0
$0
|